ULTRA LONG: BioFreedom Ultra
A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System
Sponsor: Biosensors Europe SA
A NA clinical study on Coronary Artery Disease and High Bleeding Risk Patients, this trial is ongoing. The trial is conducted by Biosensors Europe SA and has accumulated 9 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2025 — Jul 2025 [monthly]
Recruiting NA
-
Dec 2024 — Feb 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2023 — Apr 2024 [monthly]
Not Yet Recruiting NA
-
Aug 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Aug 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biosensors Europe SA
For direct contact, visit the study record on ClinicalTrials.gov .